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Summary
Objective: To evaluate seizure outcome following epilepsy surgery for patients with
temporal lobe epilepsy and evaluate is gender and race/ethnicity influence it.
Methods: Data were obtained from the discharge database of the University of
Alabama at Birmingham, Epilepsy Center, between 1985 and 2001. The sample
consisted of all patients with a primary diagnosis of medically intractable temporal
lobe epilepsy (TLE) who underwent anterior temporal lobectomy. Seizure recurrence
was tabulated at 7 days, 2 months, 6 months, 1, 2, 3, 4, 5, and 6 years following
surgery. Logistic regression analysis was used to model the presence of seizure
recurrence after anterior temporal lobectomy for all patients. Kaplan—Meier analysis
was done to obtain estimates and 95% CIs of seizure freedom from baseline. Baseline
variables — age at surgery, age at seizure onset, sex, side of resection, immediate
postoperative seizures, and pathology results—wereassessed as potential predictors of
eachoutcomebycomparing the survival curveswithin eachvariablewitha log rank test.
Results: Three hundred sixty-eight patients underwent surgical treatment for TLE,
mean age of 30.2 years. Thirty-five patients were African American, 43% were men.
Immediate postoperative seizures were seen in 23 patients, while seizure recurrence
occurred in 27.3% patients within a year after surgery, and in 33.6% within 6 years.
Logistic regression results showed no differences between African Americans and
whites, between males and females. The occurrence of immediate postoperative
seizures was a strong predictor of late seizure recurrence only at 1 year after surgery.
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Conclusions: The occurrence of seizures in the immediate postoperative period is
a strong predictor of later seizure recurrence. Sex and race/ethnicity do not
appear to be predictors of long-term outcome following surgery for temporal lobe
epilepsy.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Anterior temporal lobectomy (ATL), a recognized
treatment for medically refractory temporal lobe
epilepsy (TLE) for several decades, has been
recently shown to be very effective when compared
to medical treatment in a randomized controlled
trial.1 This study however, presented outcomes of
seizure freedom for only 1 year after the surgical
procedure.
Various studies have presented data regarding
long-term outcomes. These data come from var-
ious centers, bringing variability associated with
different surgical techniques and clinical evalua-
tions. On the other hand, most of the studies from
single centers recruited only small samples of
patients.2
This study is a relatively large retrospective ana-
lysis of seizure outcome and its predictors (particu-
larly gender and race/ethnicity) in patients who
underwent ATL at a single center from 1985 through
2001. Focus was placed on gender and race/ethni-
city as we found in a recent study that these vari-
ables appeared to be associated with seizure
outcome.3,4Methods
Outcomes of 368 consecutive patients who under-
went ATL for therapy resistant TLE at the Epilepsy
Centre of the University of Alabama at Birmingham,
between 1985 and 2001 were analyzed.
Sample
All patients discharged with a primary diagnosis of
medically intractable TLE were identified. The
diagnosis was based on the confirmation of an
ictal onset in either temporal region by seizure
monitoring with video-electroencephalography
(EEG) that included the following findings: Inter-
ictal temporal lobe epileptiform and nonepilepti-
form disturbance of cerebral activity, semiology
consistent with temporal lobe origin, and ictal EEG
with either initial or delayed focal patterns. Intra-
cranial EEG confirmation was required in a subset
of patients.Magnetic resonance imaging
All patients underwent imaging on a 1.5-TMRI system
using standardized protocols. We acquired sagittal
and coronal T1-weighted, coronal T2-weighted spin
echo, fluid-attenuated inversion recovery, and inver-
sion recovery sequences. We diagnosed MTS on the
basis of evidence of hippocampal atrophy and abnor-
mal signal alterations according to validated diag-
nostic criteria.5,6
Surgery and outcome
All patients who decided to undergo surgery for TLE
due to hippocampal sclerosis, malformations of cor-
tical development, and tumors in the mesial tem-
poral region, underwent a resection of 4.5—5.5 cm
of neocortex (anterior temporal lobe) and a tar-
geted resection of the amygdala and hippocampus
(including the anterior two thirds or the entire
hippocampus). The technique has been reported
in detail previously.7 Patients underwent regular
assessment for postoperative seizure control by
the treating neurologist in periodic follow-up visits
in their respective epilepsy clinic. All patients had at
least 1 year of follow-up. Outcome at the most
recent follow-up was classified as seizure free or
not seizure free. Seizure free was defined as Engel
Class I. We also included patients who still had auras
(Engel I), including in the immediate postsurgical
period, defined as 7 days after surgery.
Pathological analysis
Representative tissue samples of the hippocampus
were routinely obtained for analysis. Specimenswere
fixed in formalin and embedded in paraffin. Histolo-
gic sections of the hippocampus and temporal lobe
were stainedwith hematoxylin—eosin and glial fibril-
lary acidic protein. We diagnosed MTS according to
the presence of neuronal loss in the cornu ammonis
(CA) 1 and CA3-4 regions of the hippocampus by
qualitative criteria. If the pathological findings were
not diagnostic for MTS (inadequate sample), the
patientwas includedon thebasis ofMRI identification
of MTS. Other diagnosis were based on the histo-
pathologic evaluation of the lesions (e.g., tumors,
malformations of cortical development).
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Independent variables consisted of race/ethnicity,
age at surgery, age at habitual seizure onset, sex,
lateralization of temporal epileptogenic focus,
immediate postoperative seizures, and pathological
results. Two specific ethnic groups constituted the
race/ethnicity variable: AfricanAmerican andwhite.
Ethnicity was registered by the treating physician,
always corroborating with the patient’s last name.
The following three specific age categories were
used: younger than 25, 25—34, and 35 years or older.
Analysis methods
Multivariate logistic regression was used to investi-
gate therelationshipbetweenseizure recurrenceand
race/ethnicity, with potential confounders con-
trolled. Two sets of logistic regression models were
estimated to generate odds ratios (ORs) for seizure
recurrence after surgery for African American com-
pared to white patients, and for men compared toTable 1 Logistic regression analysis results at 1 and 6 yea
1 year unadjust
OR (95%CI)
Race/ethnicity
Non-Hispanic Caucasians Reference
African Americans 1.7 (.8—3.6)
Age at surgery
<25 years old Reference
25—34 years old 0.7 (0.4—1.3)
>34 years old 0.8 (0.5—1.5)
Age at epilepsy onset
<5 years old Reference
5—14 years old 0.8 (0.5—1.5)
>14 years old 0.7 (0.4—1.3)
Gender
Female Reference
Male 1.7 (1.1—2.8)
Pathology
MTS Reference
Normal 1.4 (0.5—3.7)
Other 1.6 (0.6—4.2)
Side of surgery/TLE
Right Reference
Left 0.8 (0.5—1.2)
Seizure frequency (seizures per month)
<4 Reference
4—9 1.5 (0.8—2.7)
>9 1.0 (0.6—1.9)
Immediate postoperative seizures 3.5 (1.5—8.4)
Unadjusted and adjusted (including the following variables: gender,
seizure frequency, and immediate postoperative seizures).women, at 1 and 6 years following surgery. The first
model incorporated only ethnicity and gender as the
independent variables and generated unadjusted
ORs for having seizure recurrence. The second set
included all independent variables described in the
preceding subsection. Statistics were computedwith
SASversion9.0 software (SAS Institute Inc.,Cary,NC).
Kaplan—Meier survival analysis was performed to
obtain estimates and 95% CIs of seizure freedom from
baseline. Baseline variables — age at surgery, age at
seizure onset, sex, side of resection, immediate post-
operative seizures, and pathology results — were
assessed as potential predictors of each outcome
by comparing the survival curveswithin each variable
with a log rank test. For each outcome, landmark
analyses were performed by obtaining yearly survival
estimates at 1 through 6 years after surgery, and
stratifying by whether patients were seizure free
(or not) through the landmark. The Kaplan—Meier
analysis provides survival estimates that are robust to
variations in follow-up duration because patients are
included in the estimates of survival to the time theyrs post-surgery
ed 1 year adjusted
OR (95%CI)
6 years adjusted
OR (95%CI)
Reference Reference
2.1 (1.0—4.5) 1.1 (0.4—3.3)
Reference Reference
0.6 (0.3—1.1) 1.1 (0.4—2.5)
0.7 (0.4—1.3) 0.9 (0.4—2.2)
Reference Reference
0.8 (0.5—1.5) 1.4 (0.6—3.3)
0.5 (0.3—1.0) 1.2 (0.5—3.0)
Reference Reference
1.8 (1.1—2.9) 1.0 (0.5—1.9)
Reference Reference
1.4 (0.5—3.9) 1.9 (0.5—7.2)
1.8 (0.7—4.8) 2.2 (0.7—2.7)
Reference Reference
0.8 (0.5—1.3) 1.3 (0.7—2.7)
Reference Reference
1.3 (0.7—2.5) 0.9 (0.4—2.2)
1.1 (0.5—2.0) 1.1 (0.5—2.7)
3.6 (1.4—8.9) 1.3 (0.4—4.9)
age at surgery, age at epilepsy onset, pathology, side of surgery,
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Table 2 Time to subsequent seizure (seizure-free
interval), presenting hazards ratio, with p value (sig-
nificance = p < 0.05) for all variables under analysis
Hazard ratio (95% CI) p-Value
Gender (male) 1.19 (0.90, 1.58) 0.216
Race (Black) 1.10 (0.69, 1.77) 0.685
Side (left) 1.03 (0.77, 1.36) 0.866
Pathology 0.880
Gliosis Referenceexperience the outcome event (first seizure) or are
lost to follow-up or death if no event occurred. We
assumed that the length of follow-up available for a
patient was not related to seizure status or severity
but, rather, was a random process.
Hazard ratios and p values were obtained from
Cox proportional hazards analyses. Like odds ratios,
a value of one represents no difference; p < 0.05
was considered to be significant.MTS 1.03 (0.56, 1.90)
Normal 1.28 (0.58, 2.87)
Other 1.00 (0.52, 1.95)
Age 1.00 (0.99, 1.02) 0.514
Age of onset 1.00 (0.99, 1.01) 0.790
Seizure frequency 1.00 (0.99, 1.01) 0.773
Figure 1 Kaplan—Meier curve, evaluating percent of
seizure free and comparing between racial/ethnic groups.Results
Three hundred sixty-eight patients underwent sur-
gical treatment for TLE. Their mean (S.D.) age was
30.2 (0.6) years. Thirty-five patients were African
American. Men represented 43% of the sample; 56%
had left-sided TLE; 27% had <4 seizures per month,
34% had 4—9, and 39% had >9. MTS was found to be
present in 66% of patients, 6% had normal patholo-
gical evaluation, and 28% had other pathology (glio-
sis, malformations of cortical development, tumors,
between others). Immediate postoperative seizures
were seen in 23 patients, while seizure recurrence
occurred in 27.3% patients within a year after sur-
gery, and in 33.6% within 6 years.
Logistic regression results are shown in Table 1.
Model 1 includes unadjusted ORs while in the multi-
variate logistic regression analysis we controlled for
all independent variables (model 2). No significant
differences were found between African Americans
and whites in age at onset, age at surgery, sex,
pathology, side of surgery, seizure frequency, and
immediate postoperative seizures (p values>0.10).
No differences were found between males and
females, African Americans and whites, groups of
age at presentation (<25, 25—34, and >34 years),
side of surgery (left vs. right), seizure frequency
(<4, 4—9, and >9 seizures per month), underlying
pathology (MTS, gliosis, normal tissue, and other)
and age of onset (<5, 5—14, and >14 years old);
with the exception of the occurrence of immediate
postoperative seizures, which was a strong predic-
tor of late seizure recurrence only at 1 year after
surgery. The Cox proportional hazard analysis did
not reveal any differences (Table 2).
Six-year survival in terms of seizure recurrence
was 33.4% for women and 29.9% for men (log rank
p = 0.185). For race/ethnicity the log rank was
p = 0.615 (see Figs. 1 and 2).Figure 2 Kaplan—Meier curve, evaluating percent of
seizure free and comparing between females and males.Discussion
Assessment of long-term outcomes is essential in
epilepsy because it is a chronic condition, and inbrain surgery for epilepsy specifically because the
effects are irreversible. While earlier studies tradi-
tionally focused on relatively short outcomes, epi-
lepsy surgery centers are now reporting long-term
outcomes in cohorts of patients with epilepsy fol-
lowing a variety of surgical interventions. Regard-
less of follow up duration, the strength of inference
318 J.G. Burneo et al.that can be derived from these studies is less robust
than that from randomized controlled trials. None-
theless, data from cohort studies still inform clinical
practice in many areas, including epilepsy. The
question of long-term outcomes may not be amen-
able to randomized trials due to feasibility and
ethical issues.8
Epilepsy outcomes following temporal lobe sur-
gery have been studied extensively in recent years.
A review of studies with 1—5 years of follow-up,9
reported freedom of disabling seizures in 63.2% of
patients (95% CI = 60, 66) and identified a trend for
better outcomes in more recent reports. Long-term
follow-up studies of temporal lobe epilepsy surgery
reveal a slightly lower seizure-free rate (median 58%
in studies using author defined outcomes, and 65% in
those using Engel’s class I classification), and a
narrower range of seizure-free rates (59—89%).
However, the results are more similar than differ-
ent. In fact, one of our most salient findings is that,
overall, long-term surgical results were consistently
similar to those of short-term studies, including
those from a randomized trial.1 This supports the
durability of the benefits of surgery in general.
When analyzing the different independent vari-
ables, we were surprised that pathological diagnosis
did not have any influence in seizure outcome. In a
previous study, patients with MTS appeared to be at
a slightly increased risk of recurrent seizures com-
pared with those with foreign tissue lesions and
normal pathology.10 In that series, all recurrences
in patients with MTS occurred after 30 months.
Explanations for these findings include the presence
of dual pathology, bilateral TLE, and incomplete
resection of the epileptogenic zone, which was
the case in 10 of 11 patients who had recurrent
seizures 10 years after ATL.11 In our study, no differ-
ences were found in between the different pathol-
ogies, and the reason is unknown.
In terms of race/ethnicity, using prospectively
collected data, we found that seizure outcomes
at 1 and 6 years after temporal lobectomy for mesial
TLE were similar among whites and African Amer-
ican patients. Although, we previously found lower
rates of epilepsy surgery in African American
patients compared with white patients, and
although a clear explanation was not found, this
was not related to access to health care in the
African American group.12
As we previously reported, a trend for higher rates
of seizure recurrence was demonstrated in African
American compared with white patients. However,
that study was limited by the small sample size and
the retrospective design.3 Subsequently, we con-
firmed that no racial/ethnic differences were found
in a study that included twomajor epilepsy centers intheUS.4 The sample of patients in the current study is
larger giving better accuracy to the results.
Potential limitations of this study include limited
geographic sampling, a small sample size for African
Americans, lack of patients of other racial/ethnic
backgrounds, and the methodology for ethnic classi-
fication. First, although the patient population con-
sisted of white and African American patients, the
information came from one epilepsy center, and it is
not representative of the general population because
other racial/ethnic groups such as Hispanics and
Asians were not included. The main reason is that
the bi-racial population in the state of Alabama has
not changed in the rural areas, despite the fact that
the urban centers are becoming more diverse (a
phenomenon seen only in of recent years). Second,
the small sample size of African Americans has to do
with the disparities we found in our previous study.12
African Americans were found to have the same
access to presurgical evaluation, but they did not
pursue the surgical treatment as often; the reasons
for this remain unknown. Finally, the potential mis-
classification of race/ethnicity remains an issue,
particularly with Hispanic patients; although the
name origin can help with this, reports of race/
ethnicity can be subjective and are infrequently
validated.13 This important consideration is not
unique to our analysis.14 Nonetheless, it is unlikely
that systematic underreporting or overreporting of a
particular group is correlated with the propensity to
perform invasive treatments like surgery.
We need to examine race/ethnicity subgroup
data when possible (especially when previous work
suggests significant differences by race or ethni-
city), as recommended by the National Institutes
of Health. Current evidence-based knowledge does
not allow us to know the potential relationship
between race/ethnicity and trial outcomes, and this
lack of understanding constitutes a barrier to using
results of clinical research to address racial/ethnic
disparities in health.15
The finding that immediate postoperative sei-
zures predict seizure recurrence at 1 year but not
at 6 years warrants a brief discussion. Explanations
for this finding would include the non-homogeneous
pattern of discontinuation of antiepileptic medica-
tions, or that certain number of patients is going to
relapse in any case, and immediate postoperative
seizures are simply a marker for the relapse happen-
ing sooner rather than later. By the time we get to 6
years, the most of the patients who were going to
relapse have relapsed, and we are left with the true
successes. Ultimately the finding could be related to
a sampling issue.
Finally, the Kaplan—Meier analysis did not
reveal any influence of gender and race/ethni-
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what it was found with the logistic regression
analysis.
In conclusion, sex and race/ethnicity do not
appear to be predictors of long-term outcome fol-
lowing surgery for temporal lobe epilepsy.References
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